All Industries

Top Life Sciences Companies

416 Life Sciences companies, sorted by total funding raised.

Singular GenomicsAcquired

Develops high-throughput spatial multiomics sequencing platforms and services for research and cl...

La Jolla, United States201–500Genomics, Life Sciences
Venture Round·$104.0M·Feb 2021
MersanaClosed

Biopharmaceutical company that is creating the next generation of antibody drug conjugates using ...

Cambridge, United States51–200Antibody Drug Conjugates, Biotech
Series C·$103.0M·Jun 2016
Paratus Sciences

Biotech company using bat genomics and informatics to discover and develop novel therapeutics for...

New York, United States11–50Biotech, Life Sciences
Pre-seed·$102.5M·Jul 2025
S
SeerIPO

Seer develops the Proteograph platform enabling deep, unbiased proteomics discovery at scale for ...

Redwood City, United States51–200Biotech, Life Sciences
Series B·$102.5M·Mar 2018
Gameto

Gameto is a biotechnology company whose mission is to redefine female reproductive health by deve...

New York, United States11–50Life Sciences
Series C·$100.0M·Aug 2025
HUTCHMED (China) LimitedIPO

Innovative commercial-stage biopharmaceutical company discovering and developing targeted therapi...

Hong Kong, Hong Kong1001–5000Biotech, Healthcare
Private Equity·$100.0M·Jan 2013
Lab1636

Harvard-Deerfield joint translational life science R&D company advancing university innovations t...

New York, United StatesBiotech, Drug Discovery
Seed·$100.0M·Mar 2019
Nordic Bioscience

Research-driven production and development of bio markers for pharma and diagnostics partners

Herlev, Denmark51–200Biotech, Life Sciences
Private Equity·$100.0M·Mar 2021
Rubicon ResearchIPO

Rubicon is a specialty generics pharmaceutical company that researches, develops, and manufacture...

Thane, IndiaLife Sciences
Growth Equity·$100.0M·Jan 2019
Lightcast Discovery

Biotech company developing a droplet-based microfluidics platform for single-cell functional anal...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series B·$97.1M·Aug 2023
Prolific Machines

Accelerating sustainable cell production

San Francisco, United States11–50Biotech, Healthcare
Series B·$97.0M·Jun 2024
Basking Biosciences

Basking Biosciences, a clinical-stage biopharmaceutical company, was founded to solve the biggest...

Columbus, United States1–10Life Sciences, Biotech
Extension Round·$94.9M·Oct 2025
Adonis

Adonis is an AI-powered revenue intelligence and automation platform built for healthcare, helpin...

New York, United States11–50Artificial Intelligence, Fintech
Series C·$93.9M·Mar 2026
Chemify Limited

Chemify is reimagining the discovery and synthesis of novel molecules for medicines and advanced ...

Glasgow, United Kingdom51–200Life Sciences
Series B·$93.0M·Oct 2025
Xilis

Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...

Durham, United States51–200Biotech, Diagnostics
Series A·$92.0M·Apr 2025
Nautilus BiotechnologyIPO

Accurate single-molecule quantification of proteins and proteoforms

Seattle, United States51–200Artificial Intelligence, Biotech
Corporate Round·$90.7M·Jul 2021
Corvia

Develops the Corvia Atrial Shunt, a transcatheter implant for HFpEF and HFmrEF, used by hospitals...

Tewksbury, United States11–50Life Sciences, Hardware
Series F·$90.0M·Jun 2025
Doccla

Doccla offers remote patient monitoring solutions for hospitals and healthcare providers.

London, United Kingdom51–200Life Sciences, Healthcare
Series B·$90.0M·Sep 2024
Tendo Systems

Healthcare technology platform delivering analytics, patient engagement, and a shoppable care mar...

Philadelphia, United States51–200Life Sciences, Data & Analytics
Growth Equity·$89.0M·Apr 2025
Conceivable

Reimagining the IVF lab to increase by 10X the number of families who can be helped to conceive.

New York, United States11–50Healthcare, Biotech
Series A·$88.0M·Sep 2025
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series A·$88.0M·Mar 2025
Tempest TherapeuticsIPO

A clinical-stage oncology company advancing small molecules that combine both targeted and immune...

Brisbane, United States11–50Biotech, Drug Discovery
Private Equity·$85.0M·Apr 2022
Atonarp

Mass spec and optical spec systems for molecular analysis in clinical diagnostics

Tokyo, JapanDiagnostics, Industrials
Series D·$83.0M·May 2021
Averna Therapeutics

Averna Therapeutics is developing genomic medicines that insert therapeutic genes into safe harbo...

Watertown, United States11–50Life Sciences, Biotech
Series A·$82.0M·Jun 2024
Qualifyze

Founded in 2019, Qualifyze is a leading company in supply chain risk management in the Life Scien...

Frankfurt, Germany51–200Life Sciences, SaaS
Series B·$82.0M·Sep 2024